| Interviewed | Not interviewed | P-value* | ||
---|---|---|---|---|---|
Female N (%) | 8 | 5 (62.5%) | 397 | 281 (70.8%) | 0.70 |
Severity of illness N (%) | Â | Â | Â | Â | Â |
Mild/moderate | 8 | 4 (57.1%) | 397 | 259 (68.0%) | 0.72 |
Severe | 8 | 3 (42.9%) | 397 | 122 (32.0%) | Â |
Age (years), mean (SD), | 8 | 11.9 (4.3) | 397 | 13.8 (2.5) | 0.03 |
Fatigue (0 - 33), mean (SD) | 8 | 24.3 (5.5) | 382 | 24.0 (5.0) | 0.90 |
SF-36 (0 - 100), mean (SD) | 8 | 19.9 (5.9) | 383 | 20.8 (5.0) | 0.60 |
No. of Symptoms (0 - 14), mean (SD) | 7 | 9.7 (2.1) | 389 | 8.4 (2.5) | 0.17 |
Depression (HADS) (0 - 21) mean (SD) | 5 | 8.0 (4.6) | 289 | 7.0 (3.6) | 0.56 |
Anxiety (HADS) (0 - 21) mean (SD) | 5 | 9.4 (6.5) | 288 | 8.6 (4.2) | 0.66 |
Anxiety (SCAS) (0 - 90) mean (SD) | 7 | 32.7 (13.9) | 358 | 29.7 (18.3) | 0.66 |
Months to assessment, median (IQR) | 8 | 9 (7.5 - 12.5) | 397 | 13 (8 - 24) | 0.09 |